NSD2 and lung carcinoma: Moreover, depletion of NSD2 in other lung cancer cell lines with RAS activating mutations and high levels of NSD2 (Fig. 3d) had antiproliferative effects, further confirming the impact of NSD2 on the transcriptional responses of oncogenic RAS in lung cancer cell lines.